ABSTRACT
Sjögren's syndrome (SS) is a common chronic systemic autoimmune disease;however,its pathogenic mechanisms remain unclear. Proper mouse models of SS are essential for experiments. This article summarizes the recent advances in spontaneous mouse models of SS,genetically engineered mouse models of SS,and experimentally induced mouse models of SS.
Subject(s)
Animals , Humans , Mice , Disease Models, Animal , Sjogren's SyndromeABSTRACT
BACKGROUND:The gut microbiota in our intestine performs numerous useful functions and has a major impact on the host’s health. Recently some studies have revealed that the gut microbiota cannot only control intestinal activity but also affect bone metabolism by regulating the immune system. OBJECTIVE:To review the new research development in the effects of gut microbiota on bone metabolism. METHODS: We retrieved the PubMed database using “gut microbiota, immune system, bone metabolism, osteoporosis” as keywords. A total of 46 articles were included which were related to gut microbiota, immune system and bone metabolism. For the articles in the same field, those published recently or in authorized journals were selected. RESULTS AND CONCLUSION:Gut microbiota-osteoporosis research wil bridge the gaps between bone physiology, gastroenterology, immunology, and microbiology.In vivo experiments in the germ-free mice and human body have found that the gut microbiota has important effects on bone metabolism, and the intervention of antibiotics, probiotics and prebiotics has further confirmed the effects of gut microbiota on bone mass. The gut microbiota has more obvious effects on bone mass in the adolescent and post-menopause periods.
ABSTRACT
BACKGROUND:Experimental studies have showed that puerarin has an obvious protective effect on osteoporosis in ovariectomized and orchiectomized mice. But the influence of puerarin in the molecular level in the process of osteoblast differentiation is seldom reported. OBJECTIVE:To observe the effect of puerarin on the mRNA expression of alkaline phosphatase, bone sialoprotein, osteopontin and osteocalcin in osteoblasts. METHODS:The MC3T3-E1 cells from mice cultured in vitro were randomly divided into control group, puerarin group (10-6 mol/L puerarin) and estradiol group (10-7 mol/L estradiol) to observe the effects of puerarin on the differentiation of osteoblasts. mRNA expression of alkaline phosphatase, bone sialoprotein, osteopontin and osteocalcin in MC3T3-E1 cells was determined using RT-PCR method. RESULTS AND CONCLUSION:Puerarin and estradiol both could prolong the expression of alkaline phosphatase that reached the peak at 12 days. Puerarin and estradiol strengthened the mRNA expression of bone sialoprotein at 10 and 12 days, reduced expression of osteopontin at 5 and 12 days, and increased expression of osteocalcin at 10 and 12 days. These results reveal that puerarin can induce the differentiation of cultured osteoblasts by influencing osteoblast differentiation-related protein mRNA expressions, which may be one of the important molecular mechanisms of puerarin for prevention of osteoporosis.
ABSTRACT
Objective To investigate the effects of Dihuang-Yinzi on cognition and energy metabolism of AD (Alzheimer’s disease) mice. Methods 60 Male APPsw/PS1ΔE9 mice were divided into 5 groups model, positive drug (Aricept), high, medium and low dosage of Dihuang-Yinzi. C57BL/6J mice with same age were served as normal control. All groups were orally administrated for 150 days. The spatial memory and passive avoidance were measured. The energy charge, activity of complex I, II and IV of respiratory chain, enzymatic activity of ATPase and mitochondrial membrane potential were assayed. Results APPsw/PS1ΔE9 mice showed significant impairments in cognition and energy production [(0.39±0.02),(3.28± 0.37)μOD/(min?μg),(0.19±0.04)mOD/(min?μg),(0.26±0.03)mOD/(min?μg),(0.19±0.02),(0.30±0.03)、(3.49±0.73)]with compaired to normal control[(0.57±0.06),(8.74±1.57)μOD/(min?μg),(0.43± 0.02)mOD/(min?μg),(0.69±0.02)mOD/(min?μg),(0.65±0.02),(0.51±0.01),(7.41±1.28)]. Dihuang-Yinzi ameliorates cognition decline, promotes acitivity of energy production related enyzmes, and restores mitochondrial membrane potential in AD mice[(0.57 ± 0.07),(8.42 ± 1.74)μOD/(min ?μg),(0.64 ± 0.03)mOD/(min?μg),(0.68±0.04),(0.55±0.01),(6.69±1.03), P<0.01 or 0.05]. Conclusion Dihuang-Yinzi could improve cognition and energy metabolism of APPsw/PS1ΔE9 mice by protecting mitochondria from pathologic injury.
ABSTRACT
BACKGROUND: Studies confirmed that pueraria can not only prevent the reduced bone mineral density and bone mass in the ovadectomy-caused estrogen deficiency mice with osteoporosis model, also improve bone micro-structure, it can be used for osteoporosis prevention and treatment in women after menopause. Does it exhibit a similar effect fpr the treatment of male osteoporosis?OBJECTIVE: To investigate the influence of puerariae Radix (PR) crude drug on the bone mineral density (BMD) and bone micro-architecture in androgen-deficiency mice with osteoporosis model.METHODS: A total of 48 ddY male mice, aged 8 weeks and weighing 32-35 g, were randomly divided into 6 groups: sham group,orchidectomized group, PR with low, middle and high dose group, 17β-estradiol group. Each group contained 8 mice. In sham group, mice were sham operated to expose testis and epididymis, removing surrounding fat tissue; in other groups, mice were orchidectomized. After operation, sham group and model group were fed normal diet, while PR with low, middle and high dose groups were fed a diet containing 5%, 10% and 20% PR, and 17β-estradiol group was fed a normal diet with subcutaneous administration of 17β-estradiol 0.03μg/d. The diet dosage was all 4.0 g/d. Four weeks after experiment, the mice were anesthetized and killed, and the weight of the seminal vesicle was measured. Dual-energy X-ray was used to detect BMD in femurs, and micro-CT analysis for distal femur metaphysis sponge bone microstructura.RESULTS AND CONCLUSION: The whole femoral BMD was significantly decreased by 10.9% in the model group, and the decrease in BMD was completely prevented by intake of the diet with the low dose of PR. Intake of the diet with the middle dose of PR further increased BMD in the model group, but no significant differences were observed. Furthermore, the high dose of PR administration significantly increased BMD by 26.1% and 12.4% respectively compared with model group and sham operated group, and the potency was similar to that of 17β-estradiol. Intake of the diet with the low dose of PR completely prevented the decrease in trabecular bone volume and trabecular number, and restored the increase in trabecular separation in mice caused by androgen deficiency. Intake of the diet with the middle dose of PR could enhance the inhibition effect, but there was no significant difference; intake of the diet with the high dose of PR exhibited the strongest effect on the inhibition, it further significantly increased trabecular bone volume and trabecular number compared with sham operated group. The seminal vesicle was not affected by the administration of any doses of PR. Without influence on the seminal vesicle, the low and middle dose of PR can completely inhibit the decreasing BMD and bone mass caused by androgen deficiency in mice, as well as improve bone structure,high dose of PR exhibits a significant effect and similar to 17β-estradiol.
ABSTRACT
Osteoporosis is characterized by reduced bone mass and impaired micro-architectural structure, leading to an increased susceptibility to fractures. It is a complex, multifactorial disorder resulting from genetic factors, environmental factors and gene-environment interactions. Currently there are three opinions on the main pathogenesis of primary osteoporosis in traditional Chinese medicine: kidney deficiency, spleen deficiency, and spleen-kidney deficiency, in which disagreement remains. In this paper, the authors combine the modern etiology of osteoporosis to explain scientific connotation of the three opinions, aiming to comprehend the pathogenesis of primary osteoporosis and strengthen the communication between traditional Chinese medicine and Western medicine, and trying to evaluate the clinical curative effect on osteoporosis.